Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

Sierra Boughton's doctor insisted her heavy, painful periods were normal, but then at just 24, she received devastating news.

The findings of the study showed that adenocarcinoma, accounted for 53-70 per cent of the lung cancer cases in non-smokers globally in 2022.

While screenings and vaccinations have brought down cervical cancer rates for millions of women, in some age groups, cases have been rising.

TWO women lose their lives to cervical cancer every day in the UK. Like all types of the disease, the earlier it’s caught, the better. Around 95 per cent of those diagnosed at stage 1 will ...

Thousands of women are diagnosed with the cancer every year but symptoms often do not appear until it has grown and can easily be mistaken ...

High-risk HPVs cause cervical dysplasia and carcinoma in situ, which if locally confined can be successfully treated but if left untreated can progress to cervical carcinoma. There is usually a ...

Previously, clinical research findings on cadonilimab in the treatment of various malignancies have been published in internationally renowned journals such as The Lancet, The Lancet Oncology, Nature ...

Three exposed women (under 30 years of age) with clear cell adenocarcinoma of the vagina were identified (approximately 1:1600 DES daughters), which confirms the incidence rate of adenocarcinoma ...

cervical adenocarcinoma in situ [AIS], and invasive carcinoma), CIN 3, and CIN 3 or worse (CIN 3+, excluding CIN 2). According to the 2009 KPNC cervical cancer screening guidelines, ECC is ...

A mother-of-one is urging people to ensure they have regular cervical screenings, saying that the routine test "truly saved my life". Ali Alcock from Corwen, Denbighshire, said the test led to her ...